Prevention of corticosteroid-induced osteoporosis: Results of a patient survey
Open Access
- 1 August 1999
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (8) , 1736-1739
- https://doi.org/10.1002/1529-0131(199908)42:8<1736::aid-anr24>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Calcium and Vitamin D3Supplementation Prevents Bone Loss in the Spine Secondary to Low-Dose Corticosteroids in Patients with Rheumatoid ArthritisAnnals of Internal Medicine, 1996
- Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosisArthritis & Rheumatism, 1996
- A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumaticaCalcified Tissue International, 1996
- Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroidsArthritis & Rheumatism, 1994
- Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse eventsThe American Journal of Medicine, 1994
- Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and CalcitoninNew England Journal of Medicine, 1993
- Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone lossJournal of Bone and Mineral Research, 1992
- Salmon calcitonin in the therapy of corticoid-induced osteoporosisEuropean Journal of Clinical Pharmacology, 1987